| Melichar B, Hyspler R, Dragounová E, et al.
Intestinal permeability and toxicity of second-line therapeutic agents in ovarian cancer. [Comment, Letter, Research Support, Non-U.S. Gov't]
Tumori 2008 Jul-Aug; 94(4):624-6.
Full Citation | | Corvò R
[In Process Citation] [Journal Article]
Tumori 2008 Jul-Aug; 94(4):suppl 30-3.
Full Citation | | Benasso M
[In Process Citation] [Journal Article]
Tumori 2008 Jul-Aug; 94(4):suppl 26-9.
Full Citation | | Benasso M, Corvò R
[In Process Citation] [Journal Article]
Tumori 2008 Jul-Aug; 94(4):suppl 24-5.
Full Citation | | Longo F, Mansueto G
[In Process Citation] [Journal Article]
Tumori 2008 Jul-Aug; 94(4):suppl 15-23.
Full Citation | | Mansueto G, Longo F
[In Process Citation] [Journal Article]
Tumori 2008 Jul-Aug; 94(4):suppl 1-14.
Full Citation | | Zanon C
Phase 0 trial as first human study in translational research in medical technology. [Letter]
Tumori 2008 Jul-Aug; 94(4):626-7.
Full Citation | Find Related Articles | | Ballardini P, Gamberini S, Margutti G, et al.
Hepatic abscess and silent underlying colon cancer: an emerging association? [Comment, Letter]
Tumori 2008 Jul-Aug; 94(4):624.
Full Citation | | Tassinari D, Santelmo C, Tombesi P, et al.
Clinical guidelines in advanced cancer: why we cannot avoid an evidence-based model. [Comment, Letter]
Tumori 2008 Jul-Aug; 94(4):622-3.
Full Citation | Find Related Articles | | De Padova S, Carlà G, Maniglia R, et al.
Communication near the end of life. [Comment, Letter]
Tumori 2008 Jul-Aug; 94(4):621; author reply 621-2.
Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
